Allianz Asset Management’s Flexion Therapeutics, Inc. FLXN Stock Holding History
Bought
Maintained
Sold
Other funds holding FLXN
MVP
WA
TGHSA
Allianz Asset Management's FLXN Position: Q2 2019 in Review
Allianz Asset Management sold out of Flexion Therapeutics, Inc. (FLXN) in Q2 2019, closing a stake of 119,121 shares — an estimated $1.49M sold.
Allianz Asset Management first reported a position in FLXN in Q3 2015 and held it in 15 quarters. The position peaked at $7.9M in Q4 2017. 129 funds tracked by Wall St. Rank hold FLXN as of Q2 2019.
- Allianz Asset Management reported no remaining Flexion Therapeutics, Inc. position as of Q2 2019 after selling out during the quarter.
- Allianz Asset Management sold 119,121 Flexion Therapeutics, Inc. shares in Q2 2019, an estimated $1.49M.
- Allianz Asset Management first reported a position in Flexion Therapeutics, Inc. in Q3 2015 and held it in 15 quarters.
- Allianz Asset Management's Flexion Therapeutics, Inc. position peaked at $7.9M in Q4 2017.
- 129 funds tracked by Wall St. Rank held Flexion Therapeutics, Inc. as of Q2 2019.
Based on Allianz Asset Management's 13F filing for Q2 2019, filed 8 Aug 2019.